Mathieu Lepage

Title: The Innovative Contributions of Mathieu Lepage

Introduction

Mathieu Lepage is a notable inventor based in L'Huisserie, France. He has made significant contributions to the field of theranostics, particularly through his innovative patent. His work exemplifies the intersection of chemistry and medical technology, showcasing the potential for advancements in diagnostic and therapeutic applications.

Latest Patents

Lepage holds a patent for "Dual mode 18F-labelled theranostic compounds and uses thereof." This patent describes a compound or molecular complex that includes a metal chelator designed for chelation with either a radioactive or non-radioactive isotope. Additionally, it features a trifluoroborate (BF)-containing moiety configured for F/F exchange or a precursor thereof, along with an optional cell-targeting domain. This innovative approach has the potential to enhance the effectiveness of theranostic applications.

Career Highlights

Throughout his career, Mathieu Lepage has worked with prominent organizations, including the Provincial Health Services Authority and the University of British Columbia. His experience in these institutions has allowed him to collaborate with leading experts in the field, furthering his research and development efforts.

Collaborations

Lepage has collaborated with notable colleagues such as David Perrin and Aron Roxin. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Mathieu Lepage's contributions to the field of theranostics through his innovative patent highlight his role as a significant inventor. His work continues to pave the way for advancements in medical technology, demonstrating the importance of innovation in improving healthcare outcomes.